Bacterial curli protein promotes the conversion of pap248-286into the amyloid sevi: Cross-seeding of dissimilar amyloid sequences

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Hartman, Kevin ^a   Brender, Jeffrey R ^a   Monde, Kazuaki ^b,c   Ono, Akira ^b   Evans, Margery L ^a   Popovych, Nataliya ^a,d   Chapman, Matthew R ^a   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c KUMAMOTO UNIVERSITY   (Japan)

^d GENENTECH INC   (United States)

Author keywords

Functional amyloid; HIV; Kinetics; Seeding; Strain

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; BACTERIAL PROTEIN; CURLI FIBER; PROTEIN CSGA; PROTEIN CSGB; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY; VIRUS INFECTIVITY;

EID: 84877126391     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.5     Document Type: Article

References (68)

1. Apostol MI,Wiltzius JJW, Sawaya MR, Cascio D, Eisenberg D. 2011. Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry 50:2456-2463.
2. Arnold F, Schnell J, Zirafi O, Sturzel C,Meier C,Weil T, Standker L, ForssmannWG, Roan NR, GreeneWC, Kirchhoff F,Munch J. 2012. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. Journal of Virology 86:1244-1249.
3. Auer S, Trovato A, Vendruscolo M. 2009. A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation. PLOS Computational Biology 5:e1000458.
4. Barnhart MM, Chapman MR. 2006. Curli biogenesis and function. Annual Review Microbiology 60:131-147.
5. Cabaleiro-Lago C, Lynch I, Dawson KA, Linse S. 2010. Inhibition of IAPP and IAPP((20-29)) fibrillation by polymeric nanoparticles. Langmuir 26:3453-3461.
6. Capule CC, Brown C, Olsen JS, Dewhurst S, Yang J. 2012. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection. Journal of American Chemical Society 134:905-908.
7. Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V,Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ. 2009. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nature Chemical Biology 5:913-919.
8. Chien P,Weissman JS, DePace AH. 2004. Emerging principles of conformation based prion inheritance. Annual Review Biochemistry 73:617-656.
9. Cloe AL, Orgel JPRO, Sachleben JR, Tycko R,Meredith SC. 2011. The Japanese Mutant A (1E22-A(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of Wild-Type A(1-40) into atypical fibrils by 1E22-A(1-39). Biochemistry 50:2026-2039.
10. Cohen SIA, Vendruscolo M, Dobson CM, Knowles TPJ. 2011. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. Journal of Chemisry Physics 135:065105-1-065105-16.
11. Colletier JP, Laganowsky A, Landau M, Zhao ML, Soriaga AB, Goldschmidt L, Flot D, Cascio D, Sawaya MR, Eisenberg D. 2011. Molecular basis for amyloid-beta polymorphism. Proceedings of the National Academy of Sciences of the United States of America 108:16938-16943.
12. Dobson CB,Wozniak MA, Itzhaki RF. 2003. Do infectious agents play a role in dementia? Trends Microbiology 11:312-317.
13. Dzwolak W, Jansen R, Smirnovas V, Loksztejn A, Porowski S,Winter R. 2005. Templatecontrolled conformational patterns of insulin fibrillar self-assembly reflect history of solvation of the amyloid nuclei. Physical Chemistry Chemical Physics 7:1349-1351.
14. Eisenberg D, Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, Zirafi O, Stevens JT, Munch J, Baker D. 2011. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475:96-U117.
15. Foo CK, Ohhashi Y, Kelly MJS, Tanaka M,Weissman JS. 2011. Radically different amyloid conformations dictate the seeding specificity of a chimeric Sup35 prion. Journal of Molecular Biology 408:1-8.
16. Gerard HC, Dreses-Werringloer U,Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH, Bordayo EZ,Whittum-Hudson JA, Hudson AP. 2006. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunology and Medical Microbiology 48:355-366.
17. Gervaix A,West D, Leoni LM, Richman DD,WongStaal F, Corbeil J. 1997. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proceedings of the National Academy of Sciences of the United States of America 94:4653-4658.
18. Giehm L, Otzen DE. 2010. Strategies to increase the reproducibility of protein fibrillization in plate reader assays. Analytical Biochemistry 400:270-281.
19. Hammer ND, Schmidt JC, Chapman MR. 2007. The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization. Proceedings of the National Academy of Sciences of the United States of America 104:12494-12499.
20. Han HY,Weinreb PH, Lansbury PT. 1995. The core Alzheimers peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid - Is NAC a common trigger or target in neurodegenerative disease? Chemical Biology 2:163-169.
21. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. 2009. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proceedings of the National Academy of Sciences of the United States of America 106:9033-9038.
22. Hinz J, Gierasch LM, Ignatova Z. 2008. Orthogonal cross-seeding: an approach to explore protein aggregates in living cells. Biochemistry 47:4196-4200.
23. Horvath I,Weise CF, Andersson EK, Chorell E, Sellstedt M, Bengtsson C, Olofsson A, Hultgren SJ, Chapman M,Wolf-Watz M, Almqvist F,Wittung-Stafshede P. 2012. Mechanisms of protein oligomerization: inhibitor of functional amyloids templates alpha-synuclein fibrillation. Journal of American Chemical Society 134:3439-3444.
24. Jarrett JT, Lansbury PT. 1992. Amyloid fibril formation requires a chemically discriminating nucleation event - Studies of an amyloidogenic sequence from the bacterial protein Osmb. Biochemistry 31:12345-12352.
25. Jordal PB, Dueholm MS, Larsen P, Petersen SV, Enghild JJ, Christiansen G, Hojrup P, Nielsen PH, Otzen DE. 2009. Widespread abundance of functional bacterial amyloid in mycolata and other gram-positive bacteria. Applied Environmental Microbiology 75:4101-4110.
26. Kim KA, Yolamanova M, Zirafi O, Roan NR, Standker L, ForssmannWG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, GreeneWC, Kirchhoff F,Muench J. 2010. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 7:55-67.
27. Knowles TPJ,Waudby CA, Devlin GL, Cohen SIA, Aguzzi A, Vendruscolo M, Terentjev EM, Welland ME, Dobson CM. 2009. An analytical solution to the kinetics of breakable filament assembly. Science 326:1533-1537.
28. Krebs MR,Morozova-Roche LA, Daniel K, Robinson CV, Dobson CM. 2004. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sciences 13:1933-1938
29. Linse B, Linse S. 2011. Monte Carlo simulations of protein amyloid formation reveal origin of sigmoidal aggregation kinetics. Molecular Biosystems 7:2296-2303.
30. Little CS, Hammond CJ,MacIntyre A, Balin BJ, Appelt DM. 2004. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiology of Aging 25:419-429.
31. Ma BY, Nussinov R. 2012. Selective molecular recognition in amyloid growth and transmission and cross-species barriers. Journal of Molecular Biology 421:172-184.
32. MacPhee CE, Dobson CM. 2000. Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures. Journal of American Chemical Society 122:12707-12713.
33. Manzoni C, Colombo L, Bigini P, Diana V, Cagnotto A,Messa M, Lupi M, Bonetto V, Pignataro M, Airoldi C, Sironi E,Williams A, Salmona M. 2011. The molecular assembly of amyloid A controls its neurotoxicity and binding to cellular proteins. PLOS ONE 6:e24909
34. Martellini JA, Cole AL, Svoboda P, Stuchlik O, Chen LM, Chai KX, Gangrade BK, Sorensen OE, Pohl J, Cole AM. 2011. HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma. PLOS ONE 6:e16285.
35. Miklossy J. 2008. Chronic inflammation and amyloidogenesis in Alzheimer's disease - Role of spirochetes. Journal of Alzheimer's Disease 13:381-391.
36. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ. 2004. Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. Journal of Alzheimer's Disease 6:639-649.
37. Morales R, Estrada LD, Diaz-Espinoza R,Morales-Scheihing D, Jara MC, Castilla J, Soto C. 2010. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. Journal of Neuroscience 30:4528-4535.
38. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M,Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW,Mothes W, Grivel JC,Margolis L, Keppler OT, ForssmannWG, Kirchhoff F. 2007. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131:1059-1071.
39. Naiki H, Higuchi K, Nakakuki K, Takeda T. 1991. Kinetic analysis of amyloid fibril polymerization in vitro. Laboratory Investigation 65:104-110.
40. Olsen JS, Brown C, Capule CC, Rubinshtein M, Doran TM, Srivastava RK, Feng C, Nilsson BL, Yang J, Dewhurst S. 2010. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection. Journal of Biological Chemistry 285:35488-35496.
41. 248-286)) peptide. Journal of Biological Chemistry 287:11842-11849.
42. Olzscha H, Schermann SM,Woerner AC, Pinkert S, Hecht MH, Tartaglia GG, Vendruscolo M, Hayer-Hartl M, Hartl FU, Vabulas RM. 2011. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144:67-78.
43. O'Nuallain B,Williams AD,Westermark P,Wetzel R. 2004. Seeding specificity in amyloid growth induced by heterologous fibrils. Journal of Biological Chemistry 279:17490-17499.
44. Ono A,Monde K, Chukkapalli V. 2011. Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate. Journal of Virology 85:3584-3595 DOI 10.1128/JVI.02266-10
45. Padrick SB,Miranker AD. 2002. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 41:4694-4703.
46. Perelson AS, Neumann AU,Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
47. Pronchik J, He XL, Giurleo JT, Talaga DS. 2010. In vitro formation of amyloid from alpha-synuclein is dominated by reactions at hydrophobic interfaces. Journal of American Chemical Society 132:9797-9803.
48. Rajan RS, Illing ME, Bence NF, Kopito RR. 2001. Specificity in intracellular protein aggregation and inclusion body formation. Proceedings of the National Academy of Sciences of the United States of America 98:13060-13065.
49. Roan NR,Muller JA, Liu HC, Chu S, Arnold F, Sturzel CM,Walther P, Dong M,Witkowska HE, Kirchhoff F,Munch J, GreeneWC. 2011. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV Infection. Cell Host & Microbe 10:541-550.
50. Roan NR,Munch J, Arhel N,Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, GreeneWC. 2009. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. Journal of Virology 83:73-80.
51. Roan NR, Sowinski S,Munch J, Kirchhoff F, GreeneWC. 2010. Aminoquinoline surfen inhibits the action of SEVI (Semen-derived Enhancer of Viral Infection). Journal of Biological Chemistry 285:1861-1869.
52. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M,Wiltzius JJW,McFarlane HT,Madsen AO, Riekel C, Eisenberg D. 2007. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453-457.
53. Siddiqua A, Luo Y,Meyer V, Swanson MA, Yu X,Wei GH, Zheng J, Eaton GR,Ma BY, Nussinov R, Eaton SS,Margittai M. 2012. Conformational Basis for asymmetric seeding barrier in filaments of three- and four-repeat tau. Journal of American Chemical Society 134:10271-10278.
54. Suzuki Y, Brender JR, Hartman K, Ramamoorthy A,Marsh EN. 2012. Alternative pathways of human islet amyloid polypeptide aggregation distinguished by 19F nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry 51:8154-8162.
55. Thomas JA, Ott DE, Gorelick RJ. 2007. Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions. Journal of Virology 81:4367-4370.
56. Thurman AR, Doncel GF. 2010. Innate immunity and inflammatory response to trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. American Journal of Reproductive Immunology 65:89-98.
57. Tukel C,Wilson RP, Nishimori JH, Pezeshki M, Chromy BA, Baumler AJ. 2009. Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. Cell Host Microbe 6:45-53.
58. Wang X, Hammer ND, Chapman MR. 2008. The molecular basis of functional bacterial amyloid polymerization and nucleation. Journal of Biological Chemistry 283:21530-21539.
59. Wang XA, Smith DR, Jones JW, Chapman MR. 2007. In vitro polymerization of a functional Escherichia coli amyloid protein. Journal of Biological Chemistry 282:3713-3719.
60. Wasmer C, Zimmer A, Sabate R, Soragni A, Saupe SJ, Ritter C,Meier BH. 2010. Structural similarity between the prion domain of HET-s and a homologue can explain amyloid cross-seeding in spite of limited sequence identity. Journal of Molecular Biology 402:311-325.
61. Westermark P, Lundmark K,Westermark GT. 2009. Fibrils from designed non-amyloid-related synthetic peptides induce aa-amyloidosis during inflammation in an animal model. PLOS ONE 4:e6041.
62. Wiltzius JJW, Landau M, Nelson R, Sawaya MR, Apostol MI, Goldschmidt L, Soriaga AB, Cascio D, Rajashankar K, Eisenberg D. 2009. Molecular mechanisms for protein-encoded inheritance. Nature of Structural Molecular Biology 16:973-U998.
63. WurmM, Schambach A, Lindemann D, Hanenberg H, Standker L, ForssmannWG, Blasczyk R, Horn PA. 2010. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. Journal of General Medicine 12:137-146.
64. Xue WF, Homans SW, Radford SE. 2008. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proceedings of the National Academy of Sciences of the United States of America 105:8926-8931.
65. Yagi H, Kusaka E, Hongo K,Mizobata T, Kawata Y. 2005. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins, Implications for the mechanism of transmissible conformational diseases. Journal of Biological Chemistry 280:38609-38616.
66. Ye ZQ, French KC, Popova LA, Lednev IK, Lopez MM,Makhatadze GI. 2009. Mechanism of fibril formation by a 39-Residue Peptide (PAPf39) from human prostatic acidic phosphatase. Biochemistry 48:11582-11591.
67. Yin J, Chen RZ, Liu CL. 2009. Nucleic acid induced protein aggregation and its role in biology and pathology. Frontiers in Bioscience 14:5084-5106.
68. Yu X, Luo Y, Dinkel P, Zheng J,Wei GH,Margittai M, Nussinov R,Ma BY. 2012. Cross-seeding and conformational selection between three- and four-repeat human tau proteins. Journal of Biology Chemistry 287:14950-14959.